发帖
每发1个新帖
可以获得0.5个丁当奖励
回帖

【medical-news】新英格兰医学杂志发表泰国艾滋疫苗临床试验结果

查看全部
页码直达：
直达末页

楼主

铁杆站友

1楼

这个帖子发布于10年零286天前，其中的信息可能已发生改变或有所发展。

新英格兰医学杂志发表泰国艾滋疫苗临床试验结果

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

ABSTRACT

Background The development of a safe and effective vaccine against the human immunodeficiency virus type 1 (HIV-1) is critical to pandemic control.

Methods In a community-based, randomized, multicenter, double-blind, placebo-controlled efficacy trial, we evaluated four priming injections of a recombinant canarypox vector vaccine (ALVAC-HIV [vCP1521]) plus two booster injections of a recombinant glycoprotein 120 subunit vaccine (AIDSVAX B/E). The vaccine and placebo injections were administered to 16,402 healthy men and women between the ages of 18 and 30 years in Rayong and Chon Buri provinces in Thailand. The volunteers, primarily at heterosexual risk for HIV infection, were monitored for the coprimary end points: HIV-1 infection and early HIV-1 viremia, at the end of the 6-month vaccination series and every 6 months thereafter for 3 years.

Results In the intention-to-treat analysis involving 16,402 subjects, there was a trend toward the prevention of HIV-1 infection among the vaccine recipients, with a vaccine efficacy of 26.4% (95% confidence interval [CI], –4.0 to 47.9; P=0.08). In the per-protocol analysis involving 12,452 subjects, the vaccine efficacy was 26.2% (95% CI, –13.3 to 51.9; P=0.16). In the modified intention-to-treat analysis involving 16,395 subjects (with the exclusion of 7 subjects who were found to have had HIV-1 infection at baseline), the vaccine efficacy was 31.2% (95% CI, 1.1 to 51.2; P=0.04). Vaccination did not affect the degree of viremia or the CD4+ T-cell count in subjects in whom HIV-1 infection was subsequently diagnosed.

Conclusions This ALVAC-HIV and AIDSVAX B/E vaccine regimen may reduce the risk of HIV infection in a community-based population with largely heterosexual risk. Vaccination did not affect the viral load or CD4+ count in subjects with HIV infection. Although the results show only a modest benefit, they offer insight for future research. (ClinicalTrials.gov number, NCT00223080 [ClinicalTrials.gov] .)

临床论文全文下载
http://content.nejm.org/cgi/content/full/NEJMoa0908492

邀请讨论

搜索

2009-10-25 14:14 浏览 : 2062 回复 : 8

投票
收藏 2
打赏
引用
分享
- 微信扫一扫
- 新浪微博
- 丁香客
- 复制网址
举报
- 广告宣传推广
- 政治敏感、违法虚假信息
- 恶意灌水、重复发帖
- 违规侵权、站友争执
- 附件异常、链接失效
- 其他

• 老家二乙医院编制和杭州三甲医院事业编，考虑生活实际如何选？

科技动态

【medical-news】新英格兰医学杂志发表泰国艾滋疫苗临床试验结果

提示

丁香园旗下网站

关于丁香园

官方链接

科技动态

分享到：

微信扫一扫

【medical-news】新英格兰医学杂志发表泰国艾滋疫苗临床试验结果

微信扫一扫

提示

丁香园旗下网站

关于丁香园

官方链接